Rosarelis Torres, PhD

Vanda Pharmaceuticals, Inc, Washington, DC; Rosarelis Torres, PhD, 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037 ([email protected])

JCP
Efficacy and Safety of Iloperidone in Bipolar Mania
Original Research

January 15, 2024

At 4 weeks of treatment, patients receiving iloperidone showed significant improvement on the Young Mania Rating Scale versus those receiving placebo.
Rosarelis Torres, Emily L. Czeisler, Sean R. Chadwick, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe